209 related articles for article (PubMed ID: 33439775)
1. Global changes to HepG2 cell metabolism in response to galactose treatment.
Skolik RA; Solocinski J; Konkle ME; Chakraborty N; Menze MA
Am J Physiol Cell Physiol; 2021 May; 320(5):C778-C793. PubMed ID: 33439775
[TBL] [Abstract][Full Text] [Related]
2. SR4 Uncouples Mitochondrial Oxidative Phosphorylation, Modulates AMP-dependent Kinase (AMPK)-Mammalian Target of Rapamycin (mTOR) Signaling, and Inhibits Proliferation of HepG2 Hepatocarcinoma Cells.
Figarola JL; Singhal J; Tompkins JD; Rogers GW; Warden C; Horne D; Riggs AD; Awasthi S; Singhal SS
J Biol Chem; 2015 Dec; 290(51):30321-41. PubMed ID: 26534958
[TBL] [Abstract][Full Text] [Related]
3. Sodium valproate induces mitochondrial respiration dysfunction in HepG2 in vitro cell model.
Komulainen T; Lodge T; Hinttala R; Bolszak M; Pietilä M; Koivunen P; Hakkola J; Poulton J; Morten KJ; Uusimaa J
Toxicology; 2015 May; 331():47-56. PubMed ID: 25745980
[TBL] [Abstract][Full Text] [Related]
4. β-Catenin regulates hepatic mitochondrial function and energy balance in mice.
Lehwald N; Tao GZ; Jang KY; Papandreou I; Liu B; Liu B; Pysz MA; Willmann JK; Knoefel WT; Denko NC; Sylvester KG
Gastroenterology; 2012 Sep; 143(3):754-764. PubMed ID: 22684045
[TBL] [Abstract][Full Text] [Related]
5. Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis.
Kowalik MA; Guzzo G; Morandi A; Perra A; Menegon S; Masgras I; Trevisan E; Angioni MM; Fornari F; Quagliata L; Ledda-Columbano GM; Gramantieri L; Terracciano L; Giordano S; Chiarugi P; Rasola A; Columbano A
Oncotarget; 2016 May; 7(22):32375-93. PubMed ID: 27070090
[TBL] [Abstract][Full Text] [Related]
6. Dehydroepiandrosterone-induced changes in mitochondrial proteins contribute to phenotypic alterations in hepatoma cells.
Cheng ML; Chi LM; Wu PR; Ho HY
Biochem Pharmacol; 2016 Oct; 117():20-34. PubMed ID: 27501919
[TBL] [Abstract][Full Text] [Related]
7. Modulation of cellular energetics by galactose and pioglitazone.
Grimm D; Altamirano L; Paudel S; Welker L; Konkle ME; Chakraborty N; Menze MA
Cell Tissue Res; 2017 Sep; 369(3):641-646. PubMed ID: 28776185
[TBL] [Abstract][Full Text] [Related]
8. Can Galactose Be Converted to Glucose in HepG2 Cells? Improving the
Xu Q; Liu L; Vu H; Kuhls M; Aslamkhan AG; Liaw A; Yu Y; Kaczor A; Ruth M; Wei C; Imredy J; Lebron J; Pearson K; Gonzalez R; Mitra K; Sistare FD
Chem Res Toxicol; 2019 Aug; 32(8):1528-1544. PubMed ID: 31271030
[TBL] [Abstract][Full Text] [Related]
9. Glucose-modulated mitochondria adaptation in tumor cells: a focus on ATP synthase and inhibitor Factor 1.
Domenis R; Bisetto E; Rossi D; Comelli M; Mavelli I
Int J Mol Sci; 2012; 13(2):1933-1950. PubMed ID: 22408432
[TBL] [Abstract][Full Text] [Related]
10. Rewiring carbohydrate catabolism differentially affects survival of pancreatic cancer cell lines with diverse metabolic profiles.
Tataranni T; Agriesti F; Ruggieri V; Mazzoccoli C; Simeon V; Laurenzana I; Scrima R; Pazienza V; Capitanio N; Piccoli C
Oncotarget; 2017 Jun; 8(25):41265-41281. PubMed ID: 28476035
[TBL] [Abstract][Full Text] [Related]
11. Impairment of oxidative phosphorylation increases the toxicity of SYD-1 on hepatocarcinoma cells (HepG2).
Brandt AP; Gozzi GJ; Pires Ado R; Martinez GR; Dos Santos Canuto AV; Echevarria A; Di Pietro A; Cadena SM
Chem Biol Interact; 2016 Aug; 256():154-60. PubMed ID: 27417255
[TBL] [Abstract][Full Text] [Related]
12. The neglected foodborne mycotoxin Fusaric acid induces bioenergetic adaptations by switching energy metabolism from mitochondrial processes to glycolysis in a human liver (HepG2) cell line.
Sheik Abdul N; Nagiah S; Chuturgoon AA
Toxicol Lett; 2020 Jan; 318():74-85. PubMed ID: 31654802
[TBL] [Abstract][Full Text] [Related]
13. Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment.
Cassim S; Raymond VA; Dehbidi-Assadzadeh L; Lapierre P; Bilodeau M
Cell Cycle; 2018; 17(7):903-916. PubMed ID: 29633904
[TBL] [Abstract][Full Text] [Related]
14. Metabolic profiling of normal hepatocyte and hepatocellular carcinoma cells via
Chen Y; Chen Z; Feng JH; Chen YB; Liao NS; Su Y; Zou CY
Cell Biol Int; 2018 Apr; 42(4):425-434. PubMed ID: 29144590
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of Glucotoxicity, Oxidative Stress, Apoptosis and Mitochondrial Dysfunction in HepG2 Cells by Palmitic Acid.
Alnahdi A; John A; Raza H
Nutrients; 2019 Aug; 11(9):. PubMed ID: 31443411
[TBL] [Abstract][Full Text] [Related]
16. Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice.
Fan T; Rong Z; Dong J; Li J; Wang K; Wang X; Li H; Chen J; Wang F; Wang J; Wang A
Cancer Med; 2017 Oct; 6(10):2370-2384. PubMed ID: 28941178
[TBL] [Abstract][Full Text] [Related]
17. Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro.
Dykens JA; Jamieson J; Marroquin L; Nadanaciva S; Billis PA; Will Y
Toxicol Appl Pharmacol; 2008 Dec; 233(2):203-10. PubMed ID: 18817800
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial UQCC3 Modulates Hypoxia Adaptation by Orchestrating OXPHOS and Glycolysis in Hepatocellular Carcinoma.
Yang Y; Zhang G; Guo F; Li Q; Luo H; Shu Y; Shen Y; Gan J; Xu L; Yang H
Cell Rep; 2020 Nov; 33(5):108340. PubMed ID: 33147459
[TBL] [Abstract][Full Text] [Related]
19. A Multi-Omics Study Revealing the Metabolic Effects of Estrogen in Liver Cancer Cells HepG2.
Shen M; Xu M; Zhong F; Crist MC; Prior AB; Yang K; Allaire DM; Choueiry F; Zhu J; Shi H
Cells; 2021 Feb; 10(2):. PubMed ID: 33672651
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the effects of the water-soluble total flavonoids from Isodon lophanthoides var.gerardianus (Benth.) H. Hara on apoptosis in HepG2 cell: Investigation of the most relevant mechanisms.
Feng CP; Tang HM; Huang S; Hou SZ; Liang J; Huang W; Lai XP
J Ethnopharmacol; 2016 Jul; 188():70-9. PubMed ID: 27132715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
